Drug Trial Radar · NCT02959983
Efficacy of Eluxadoline in the Treatment of Irritable Bowel Syndrome With Diarrhea in Patients With Inadequate Control of Symptoms With Prior Loperamide Use
Last checked: Nov 20, 2026Latest source record: Feb 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
346
Actual
Start
Oct 25, 2016
Primary completion
Jan 22, 2018
Study completion Jan 22, 2018
Sponsor
- Lead sponsor
- AllerganAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Nov 9, 2016
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the efficacy and safety of eluxadoline 100 milligrams (mg) twice a day (BID) versus placebo for the treatment of patients with Irritable Bowel Syndrome with Diarrhea (IBS-D) who report that the use of loperamide in the prior 12 months failed to provide control of their IBS-D symptoms.
Conditions
- Irritable Bowel Syndrome With Diarrhea
Interventions
EluxadolineDrug
Eluxadoline 100 mg oral tablets BID with food.
PlaceboDrug
Placebo matching eluxadoline oral tablets BID with food.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Were Composite Responders Based on Improvements From Baseline in Daily Worst Abdominal Pain And Daily Stool Consistency ScoresTime frame: Baseline, Weeks 1 to 12
Locations
83 sites in 2 countries. Site status is shown where the registry gives one.
Clinical Research Associates, LLC
Huntsville, Alabama
The Center for Clinical Trials
Saraland, Alabama
Elite Clinical Studies
Phoenix, Arizona
Arkansas Gastroenterology
North Little Rock, Arkansas
Med Investigations
Carmichael, California
GW Research Inc
Chula Vista, California
Diagnamics Inc
Encinitas, California
Behavioral Research Specialists, LLC
Irvine, California
Providence Clinical Research
North Hollywood, California
Shahram Jacobs MD INC.
Sherman Oaks, California
Westlake Medical Research
Thousand Oaks, California
Upland Clinical Research
Upland, California
Advanced RX Clinicial Research Group, Inc.
Westminster, California
Connecticut Clinical Research Foundation
Bristol, Connecticut
Medical Research Center of Connecticut, LLC
Hamden, Connecticut
Innovative Research of West Florida, Inc.
Clearwater, Florida
Digestive Care of N. Broward
Coral Springs, Florida
Homestead Medical Research
Homestead, Florida
Clinical Neuroscience Solutions Inc.
Jacksonville, Florida
Health Awareness, Inc.
Jupiter, Florida
Precision Clinical Research LLC
Lauderdale Lakes, Florida
Pharmax Research Clinic Inc.
Miami, Florida
Well Pharma Medical Research, Corp.
Miami, Florida
Ocean Blue Medical Research Center, Inc
Miami Springs, Florida
Bravo Health Care Center
North Bay Village, Florida
Clinical Neuroscience Solutions Inc.
Orlando, Florida
Clinical Research of West Florida Inc.
Tampa, Florida
Meridien Research
Tampa, Florida
Emory University School of Medicine
Atlanta, Georgia
RNA America, LLC
Buford, Georgia
Northwestern University Feinbery School of Medicine
Chicago, Illinois
Pharmakon Inc
Evergreen Park, Illinois
Investigators Research
Brownsburg, Indiana
Radiant Research, Inc.
Evansville, Indiana
Clinical Research Advantage Inc/Radiant Research Inc.
Evansville, Indiana
Gtc Research
Shawnee Mission, Kansas
Investigative Clinical Research
Annapolis, Maryland
MGG Group Co. Inc. Chevy Chase Clinical Research
Chevy Chase, Maryland
MedVadis Research Corporation
Watertown, Massachusetts
Clinical Research Insititute of Michigan LLC
Chesterfield, Michigan
Showing 40 of 83 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.